Article Text

Download PDFPDF
Utero-cutaneous fistula following caesarean section
  1. Senthil Coumary1,
  2. Indira Galidevara2,
  3. Venna Naga Daliya2 and
  4. Seetesh Ghose2
  1. 1Obstetrics and Gynecology, Mahatma Gandhi Medical College and Research Institute, Pondicherry, India
  2. 2Mahatma Gandhi Medical College and Research Institute, Pondicherry, India
  1. Correspondence to Dr Venna Naga Daliya; doctor.daliya{at}gmail.com

Abstract

A multiparous woman in her 20s, presented to the clinic with bleeding from caesarean scar site. After clinical examination and radiological evaluation with ultrasound and MR fistulogram, the diagnosis was utero-cutaneous fistula. Complete resection of fistulous tract with uterine defect closure and supportive omental patch placement was done after an intraoperative demonstration of the utero-cutaneous fistula by injecting methylene blue dye. Utero-cutaneous fistula is a rare complication after caesarean section. Cyclical bleeding from an abnormal opening in previous caesarean scar site is the classical presentation of this condition.

  • Obstetrics and gynaecology
  • Surgery

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors SC, IG, VND, SG were responsible for drafting of the text, sourcing and editing of clinical images, investigation results, drawing original diagrams and algorithms, and critical revision for important intellectual content. SC, IG, VND, SG gave final approval of the manuscript.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Case reports provide a valuable learning resource for the scientific community and can indicate areas of interest for future research. They should not be used in isolation to guide treatment choices or public health policy.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.